Literature DB >> 21353315

Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin.

Birgit Obermeier1, Laura Lovato, Reinhard Mentele, Wolfgang Brück, Ignasi Forne, Axel Imhof, Friedrich Lottspeich, Katherine W Turk, Simon N Willis, Hartmut Wekerle, Reinhard Hohlfeld, David A Hafler, Kevin C O'Connor, Klaus Dornmair.   

Abstract

We investigated the overlap shared between the immunoglobulin (Ig) proteome of the cerebrospinal fluid (CSF) and the B cell Ig-transcriptome of CSF and the central nervous system (CNS) tissue of three patients with multiple sclerosis. We determined the IgG-proteomes of CSF by mass spectrometry, and compared them to the IgG-transcriptomes from CSF and brain lesions, which were analyzed by cDNA cloning. Characteristic peptides that were identified in the CSF-proteome could also be detected in the transcriptomes of both, brain lesions and CSF, providing evidence for a strong overlap of the IgG repertoires in brain lesions and in the CSF.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353315      PMCID: PMC3090654          DOI: 10.1016/j.jneuroim.2011.01.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

Review 1.  Multiple sclerosis.

Authors:  David A Hafler; Jacqueline M Slavik; David E Anderson; Kevin C O'Connor; Philip De Jager; Clare Baecher-Allan
Journal:  Immunol Rev       Date:  2005-04       Impact factor: 12.988

Review 2.  B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.

Authors:  Edgar Meinl; Markus Krumbholz; Reinhard Hohlfeld
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

3.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Authors:  Birgit Obermeier; Reinhard Mentele; Joachim Malotka; Josef Kellermann; Tania Kümpfel; Hartmut Wekerle; Friedrich Lottspeich; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

4.  Restricted use of VH4 germline segments in an acute multiple sclerosis brain.

Authors:  G P Owens; H Kraus; M P Burgoon; T Smith-Jensen; M E Devlin; D H Gilden
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

5.  Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients.

Authors:  Nancy L Monson; Hans-Peter Brezinschek; Ruth I Brezinschek; Angela Mobley; Gwen K Vaughan; Elliot M Frohman; Michael K Racke; Peter E Lipsky
Journal:  J Neuroimmunol       Date:  2005-01       Impact factor: 3.478

6.  Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.

Authors:  Kevin C O'Connor; Heiner Appel; Lisa Bregoli; Matthew E Call; Ingrid Catz; Jennifer A Chan; Nicole H Moore; Kenneth G Warren; Susan J Wong; David A Hafler; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

7.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Multiple sclerosis: T-cell receptor expression in distinct brain regions.

Authors:  Andreas Junker; Jana Ivanidze; Joachim Malotka; Ingrid Eiglmeier; Hans Lassmann; Hartmut Wekerle; Edgar Meinl; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Brain       Date:  2007-09-21       Impact factor: 13.501

9.  Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.

Authors:  Hans-Christian von Büdingen; Melanie D Harrer; Sandra Kuenzle; Mirjam Meier; Norbert Goebels
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

10.  Lipid microarrays identify key mediators of autoimmune brain inflammation.

Authors:  Jennifer L Kanter; Sirisha Narayana; Peggy P Ho; Ingrid Catz; Kenneth G Warren; Raymond A Sobel; Lawrence Steinman; William H Robinson
Journal:  Nat Med       Date:  2005-12-11       Impact factor: 53.440

View more
  54 in total

Review 1.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 2.  Neuroinflammation: Ways in Which the Immune System Affects the Brain.

Authors:  Richard M Ransohoff; Dorothy Schafer; Angela Vincent; Nathalie E Blachère; Amit Bar-Or
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 3.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

4.  Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

Authors:  Ariele L Greenfield; Ravi Dandekar; Akshaya Ramesh; Erica L Eggers; Hao Wu; Sarah Laurent; William Harkin; Natalie S Pierson; Martin S Weber; Roland G Henry; Antje Bischof; Bruce Ac Cree; Stephen L Hauser; Michael R Wilson; H-Christian von Büdingen
Journal:  JCI Insight       Date:  2019-03-21

Review 5.  The anatomical and cellular basis of immune surveillance in the central nervous system.

Authors:  Richard M Ransohoff; Britta Engelhardt
Journal:  Nat Rev Immunol       Date:  2012-08-20       Impact factor: 53.106

Review 6.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

Review 7.  B cells in multiple sclerosis: connecting the dots.

Authors:  H-Christian von Büdingen; Amit Bar-Or; Scott S Zamvil
Journal:  Curr Opin Immunol       Date:  2011-10-07       Impact factor: 7.486

Review 8.  Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets.

Authors:  H-Christian von Büdingen; Arumugam Palanichamy; Klaus Lehmann-Horn; Brady A Michel; Scott S Zamvil
Journal:  Eur Neurol       Date:  2015-03-25       Impact factor: 1.710

Review 9.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

Review 10.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.